STOCK-BASED COMPENSATION (Details 5) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2014
Stock options & SARs
Weighted Average Exercise Price
Outstanding balance at the beginning of the period (in dollars per share)	$ 25.26
Granted (in dollars per share)	$ 15.74
Forfeited/Expired (in dollars per share)	$ 30.06
Exercised (in dollars per share)	$ 16.60
Outstanding balance at the end of the period (in dollars per share)	$ 20.80
Exercisable at the end of the period (in dollars per share)	$ 25.85
Unvested options, net of estimated forfeitures (in dollars per share)	$ 16.68
Weighted-Average Remaining Contractual Life
Outstanding at the end of the period	6 years 9 months 18 days
Exercisable at the end of the period	4 years 6 months
Unvested options, net of estimated forfeitures	8 years 8 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding	$ 0
Share Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Other than Options Aggregate Intrinsic Value Nonvested Awards Net of Estimated Forfeitures	$ 0
SARs
SARs outstanding
Outstanding balance at the beginning of the period (in shares)	860,000
Granted (in shares)	470,000
Forfeited/Expired (in shares)	(189,000)
Exercised (in shares)	(1,000)
Outstanding balance at the end of the period (in shares)	1,140,000
Exercisable at the end of the period (in shares)	383,000
Unvested options, net of estimated forfeitures (in shares)	686,000
Stock Options
SARs outstanding
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0
Stock options outstanding
Outstanding balance at the beginning of the period (in shares)	429,000
Forfeited/Expired (in shares)	(177,000)
Exercised (in shares)	0
Outstanding balance at the end of the period (in shares)	252,000
Exercisable at the end of the period (in shares)	246,000
Unvested options, net of estimated forfeitures (in shares)	6,000